November 2019: CBD for the Reduction of Craving and Anxiety in Heroin Use Disorder

Executive Editor Michael Roy speaks with Yasmin Hurd, Ph.D., about her research on the potential of cannabidiol (CBD) to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with heroin use disorder.

• What has past research with CBD shown in terms of its function as a treatment for mental illness? [2:29]
• Why the present study examined the potential of CBD to moderate craving and anxiety, and how these reactions were triggered among participants [4:14]
• How did the study team decide to evaluate CBD at two different doses? [5:54]
• Main findings of the study [7:42]
• Discussion of secondary outcomes and adverse events [9:02]
• Take-home messages for mental health professionals and the general public [11:37]
• Thoughts on how the medical use of CBD will fit in to the broader trend of the relaxation of marijuana laws throughout the United States [13:28]

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online. Also visit the online edition of this month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D., present highlights from the issue.

Follow the Journal on Twitter.

E-mail us at [email protected]